ABCL
ABCL
CA00288U1066
AbCellera Biologics Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
4.07B EUR
2.41B EUR
1.06B EUR
1.03B EUR
Enterprise Value
3.28B EUR
2.42B EUR
1.12B EUR
1.04B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-16.08x
--
--
--
Price to Sales
61.44x
36.36x
13.39x
14.5x
Price to Book
4.29x
2.68x
1.13x
1.06x
EV/Revenue
49.58x
36.59x
14.19x
14.71x
EV/EBITDA
-16.41x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.14%
-4.97%
-17.84%
-14.77%
ende